LB1513 Autoantibodies against collagen XVII (BP180) favor the development of cutaneous toxicity during checkpoint inhibitor therapy
Hasan Ali, O., Bomze, D., Ring, S., Berner, F., Fässler, M., Diem, S., Cozzio, A., Jochum, W., Zillikens, D., Sadik, C., Flatz, L.Volume:
138
Language:
english
Journal:
Journal of Investigative Dermatology
DOI:
10.1016/j.jid.2018.06.044
Date:
September, 2018
File:
PDF, 237 KB
english, 2018